Glycogen synthase kinase 3β and cyclin D1 expression in cervical carcinogenesis

Area of Science:

• Oncology
• Molecular Biology
• Cell Cycle Regulation

Background:

• Glycogen synthase kinase 3β (GSK3β) is a key kinase implicated in cancer development by regulating oncogenic molecules.
• Cyclin D1, a cell cycle regulator, is a known target protein of GSK3β.
• Understanding the roles of GSK3β and cyclin D1 in cervical carcinogenesis is crucial for developing targeted therapies.

Purpose of the Study:

• To evaluate the expression levels of GSK3β and cyclin D1 in cervical neoplasia across different histologic grades.
• To determine the correlation between GSK3β and cyclin D1 expression during cervical carcinogenesis.
• To investigate the association of GSK3β expression with specific histological types of cervical cancer.

Main Methods:

• Immunohistochemical analysis was employed to assess GSK3β and cyclin D1 expression.
• The study included 137 patients with normal cervical tissue, cervical intraepithelial neoplasia (CIN1 and CIN3), and invasive cervical cancers (squamous cell carcinoma and adenocarcinoma).

Main Results:

• GSK3β expression significantly increased with increasing lesion grade (P<0.001).
• Cyclin D1 expression showed a significant decrease with lesion severity (P<0.001).
• A significant inverse correlation was observed between GSK3β and cyclin D1 expression (Φ=-0.413, P<0.001).
• GSK3β expression was notably higher in squamous cell carcinoma compared to adenocarcinoma (P=0.049).

Conclusions:

• Increased GSK3β expression plays a role in cervical carcinogenesis and is inversely correlated with cyclin D1.
• GSK3β expression levels may serve as a biomarker for cervical neoplasia progression.
• The findings suggest a specific association between elevated GSK3β and squamous cell carcinoma of the cervix.